Skip to content

13F-HR filed by Atle Fund Management AB

Atle Fund Management AB filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-04-28, with 10 holding rows worth $65,212,000.

Accession
0000950123-17-003634
Filed
2017-04-28
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2017

A holdings report, 10 entries on the cover page, a total value of $65,212,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $65,213,000 with VALUE read as thousands by filing date, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AETNA INC NEW00817Y108COM89,000$11,352,000thousands by filing date
CENCORA INC COM03073E105Stock126,000$11,151,000thousands by filing date
Gilead Sciences,Inc.375558103COM117,000$7,947,000thousands by filing date
ANIKA THERAPEUTICS INC035255108COM181,573$7,888,000thousands by filing date
CHARLES RIV LABS INTL INC159864107COM85,612$7,701,000thousands by filing date
MCKESSON CORP COM58155Q103Stock51,000$7,561,000thousands by filing date
OSIRIS THERAPEUTICS INC NEW68827R108COM1,140,222$5,473,000thousands by filing date
GNC HLDGS INC36191G107COM CL A422,955$3,113,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM497,807$2,096,000thousands by filing date
IMMUCELL CORP452525306COM PAR168,323$931,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-17-003634this filing2017-04-28acceptance time not in the bulk data set